Navigation Links
Apollo Endosurgery Demonstrates Clinical Functionality of the Newly Launched OverStitch™ Endoscopic Suturing System in Bariatric Repairs and GI Therapy
Date:1/11/2011

AUSTIN, Texas, Jan. 11, 2011 /PRNewswire/ -- Apollo Endosurgery, Inc. announced preliminary results from their GEMINI suturing registry. These results confirm the procedure enabling capability of their newly-launched OveStitch™EndoscopicSuturing System in a variety of clinical cases in the esophagus, stomach and colon.

A unique device that mimics the way physicians deploy sutures by hand, the OverStitch system enables full-thickness endoscopic suturing on a flexible platform -- delivering a surgical standard of care through the flexible endoscope.

While preliminary results will be presented at the upcoming SAGES and DDW meetings, the company is reporting the successful completion of more than 60 procedures in the esophagus, stomach and colon over the last several weeks. These cases include stoma reductions, GI bleeds, repairs of fistulas, ulcers and other small defects.

Early procedures have been performed in several thought leading institutions including: Legacy Health Systems, Portland, OR; Mayo Clinic, Rochester, MN; University of California San Diego, San Diego, CA; Johns Hopkins, Baltimore, MD; Brigham and Women's, Boston, MA; California Pacific Medical Center, San Francisco, CA. Dr. Christopher Thompson of Brigham and Women's Hospital noted: "The versatility of OverStitch is incredible--- it has allowed me the increased flexibility in these recent procedures to obtain results that in many cases would have been impossible to achieve without laparoscopic or open surgical intervention."

Dennis McWilliams, CEO and President for Apollo, states, "The OverStitch Endoscopic Suturing System has enabled many procedures that previously may have required more invasive treatment.  The OverStitch system's utility and breadth of clinical applications in endoscopic tissue apposition are a result of the control and simplicity of use demonstrated during these early cases. The system shows great promise of improving the lives of thousands of patients suffering from disease and defects within the GI Tract."

Endoscopic suturing is a huge market opportunity with over 1.2 million basic procedures performed annually in the US, such as stoma and gastric reductions, fistula repair, stent fixation, and GI bleeds. Apollo is exceptionally well positioned to achieve substantial growth and advance the potential of flexible surgery -- while minimizing the trauma of endoscopic surgical access.

Apollo collects data on each case and maintains its ongoing Gemini Suturing Registy (Gastrointestinal Endoscopic MINimally Invasive) whenever an OverStitch system is employed in an endoscopic procedure.

AboutApollo Endosugery, Inc.Apollo Endosurgery, Inc. is dedicated to revolutionizing patient care through the development of flexible surgery, which is emerging from the convergence of laparoscopic surgery and therapeutic gastroenterology.  Flexible surgery minimizes the trauma of surgical access by taking advantage of natural orifices to deliver surgical tools to targeted areas. All of Apollo's products are compatible with existing flexible endoscope platforms. Apollo Endosurgery was cofounded with the Apollo Group, a unique collaboration of physicians from the Mayo Clinic, Johns Hopkins University, Medical University of South Carolina, the University of Texas Medical Branch and the Chinese University of Hong Kong. The company is funded by PTV Sciences, H.I.G. Ventures and has received a grant from the Cancer Prevention Research Institute of Texas.

For more information, visit our website (www.apolloendo.com) or contact:Lee PutmanVP of Marketing and SalesApollo Endosurgery, Inc.512-328-9990 (o)513-703-3230 (m)www.apolloendo.com
'/>"/>

SOURCE Apollo Endosurgery, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Apollo Endosurgery Completes First Clinical Case with Newly-Launched FlexShears™ Endoscopic Scissors
2. Apollo Endosurgery Completes First-in-Human Cases With New OverStitch™ Endoscopic Suturing System
3. VIDA Diagnostics Introduces Apollo™
4. IntegenX Launches the Apollo 324 System for Automated DNA Library Preparation at the ASHG Meeting
5. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
6. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
7. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
8. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
9. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
10. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
11. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... -- Varian Medical Systems (NYSE: VAR ) announced ... of fiscal year 2017 following the close of regular trading ... followed by a teleconference available to all interested parties at ... the conference call webcast will be available on the company ... and replay: ...
(Date:3/29/2017)...  NuVasive, Inc. (NASDAQ: NUVA), a leading medical ... minimally disruptive, procedurally-integrated solutions, today announced U.S. Food ... CoRoent® Small Interbody™ System indicated for intervertebral body ... spine. This marks the first U.S. clearance for ... to four contiguous levels. Cervical radiculopathy ...
(Date:3/29/2017)... 2017 NetworkNewsWire Editorial Coverage  ... There are a ... regulating marijuana, but economic arguments also favor its legalization. The ... enforcement costs. However, to legalize and regulate marijuana requires an ... (OTC: SING) ( SING Profile ), American Cannabis Company (OTC: ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... March 29, 2017 , ... Curio Wellness , ... announce the finalization of the company’s executive management team with prominent executives from both ... is Curio Wellness’ Chief Operating Officer, Ted Dumbauld , who has more than ...
(Date:3/29/2017)... ... 29, 2017 , ... The assembly of synthetic DNA has ... repetitive steps and often scientists require many different versions of DNA. Therefore, this ... in a lower error rate and cost saving for reagents and consumables. , ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... of Pittsburgh now have easier access to the robotic-assisted total-hip and partial-knee ... Network (AHN). Orthopaedic surgeons at Forbes Hospital and Jefferson Hospital recently started ...
(Date:3/29/2017)... ... March 29, 2017 , ... AvePoint , the Microsoft ... office location in Richmond, Virginia, located at the Riverfront Plaza, 901 East Byrd Street. ... Governor of Virginia Ralph S. Northam and Mayor of Richmond Levar M. Stoney. , ...
(Date:3/28/2017)... ... March 28, 2017 , ... Tuesday, March 28, 2017, ... public to take the Diabetes Risk Test to find out if they are at ... World Airports will light up the evening sky by programming the LAX pylons the ...
Breaking Medicine News(10 mins):